4.7 Article

Virome Analysis of Transfusion Recipients Reveals a Novel Human Virus That Shares Genomic Features with Hepaciviruses and Pegiviruses

期刊

MBIO
卷 6, 期 5, 页码 -

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/mBio.01466-15

关键词

-

资金

  1. NIH [HL119485, AI107631, AI109761]
  2. National Institute of Dental and Craniofacial Research, NIH
  3. BBSRC [BBS/E/D/20241864] Funding Source: UKRI
  4. Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864] Funding Source: researchfish

向作者/读者索取更多资源

To investigate the transmission of novel infectious agents by blood transfusion, we studied changes in the virome composition of blood transfusion recipients pre- and posttransfusion. Using this approach, we detected and genetically characterized a novel human virus, human hepegivirus 1 (HHpgV-1), that shares features with hepatitis C virus (HCV) and human pegivirus (HPgV; formerly called GB virus C or hepatitis G virus). HCV and HPgV belong to the genera Hepacivirus and Pegivirus of the family Flaviviridae. HHpgV-1 was found in serum samples from two blood transfusion recipients and two hemophilia patients who had received plasma-derived clotting factor concentrates. In the former, the virus was detected only in the posttransfusion samples, indicating blood-borne transmission. Both hemophiliacs were persistently viremic over periods of at least 201 and 1,981 days. The 5' untranslated region (UTR) of HHpgV-1 contained a type IV internal ribosome entry site (IRES), structurally similar to although highly divergent in sequence from that of HCV and other hepaciviruses. However, phylogenetic analysis of nonstructural genes (NS3 and NS5B) showed that HHpgV-1 forms a branch within the pegivirus clade distinct from HPgV and homologs infecting other mammalian species. In common with some pegivirus variants infecting rodents and bats, the HHpgV-1 genome encodes a short, highly basic protein upstream of E1, potentially possessing a core-like function in packaging RNA during assembly. Identification of this new human virus, HHpgV-1, expands our knowledge of the range of genome configurations of these viruses and may lead to a reevaluation of the original criteria by which the genera Hepacivirus and Pegivirus are defined. IMPORTANCE More than 30 million blood components are transfused annually in the United States alone. Surveillance for infectious agents in the blood supply is key to ensuring the safety of this critical resource for medicine and public health. Here, we report the identification of a new and highly diverse HCV/GB virus (GBV)-like virus from human serum samples. This new virus, human hepegivirus 1 (HHpgV-1), was found in serum samples from blood transfusion recipients, indicating its potential for transmission via transfusion products. We also found persistent long-term HHpgV-1 viremia in two hemophilia patients. HHpgV-1 is unique because it shares genetic similarity with both highly pathogenic HCV and the apparently nonpathogenic HPgV (GBV-C). Our results add to the list of human viruses and provide data to develop reagents to study virus transmission and disease association and for interrupting virus transmission and new human infections.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Maternal mid-gestational and child cord blood immune signatures are strongly associated with offspring risk of ASD

Xiaoyu Che, Mady Hornig, Michaeline Bresnahan, Camilla Stoltenberg, Per Magnus, Pal Suren, Siri Mjaaland, Ted Reichborn-Kjennerud, Ezra Susser, W. Ian Lipkin

Summary: This study suggests that immune activation may be a risk factor for autism spectrum disorders (ASDs) and identifies potential immune biomarkers for early diagnosis. The findings highlight the importance of gestational immunopathology in ASD and reveal sex-specific differences.

MOLECULAR PSYCHIATRY (2022)

Article Medicine, General & Internal

Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma

Lise J. Estcourt, Claudia S. Cohn, Monica B. Pagano, Claire Iannizzi, Nina Kreuzberger, Nicole Skoetz, Elizabeth S. Allen, Evan M. Bloch, Gregory Beaudoin, Arturo Casadevall, Dana V. Devine, Farid Foroutan, Thomas J. Gniadek, Ruchika Goel, Jed Gorlin, Brenda J. Grossman, Michael J. Joyner, Ryan A. Metcalf, Jay S. Raval, Todd W. Rice, Beth H. Shaz, Ralph R. Vassallo, Jeffrey L. Winters, Aaron A. R. Tobian

Summary: This article introduces the therapeutic application of convalescent plasma for COVID-19 patients and provides corresponding clinical practice guidelines. The guidelines include recommendations for the use of convalescent plasma for outpatients and inpatients, as well as for prophylactic application. For high-risk patients, it is recommended to transfuse convalescent plasma in addition to standard care, while for hospitalized patients without detectable SARS-CoV-2 antibodies, it is suggested to transfuse convalescent plasma in addition to standard care.

ANNALS OF INTERNAL MEDICINE (2022)

Article Hematology

Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storage

Jose A. Cancelas, Jamie R. Genthe, Moritz Stolla, Neeta Rugg, S. Lawrence Bailey, Shawnagay Nestheide, Beth Shaz, Samantha Mack, Kadi Schroeder, Waseem Anani, Zbigniew M. Szczepiorkowski, Larry J. Dumont, Subramanian Yegneswaran, Laurence Corash, Nina Mufti, Richard J. Benjamin, Anna C. Erickson

Summary: This study evaluated the performance of Amotosalen/UVA pathogen-reduced platelet components (PRPCs) stored for 7 days through in vitro and in vivo analysis, and found that they exhibited similar characteristics to fresh platelets.

TRANSFUSION (2022)

Article Hematology

Blood donation motivators and barriers reported by young, first-time whole blood donors: Examining the association of reported motivators and barriers with subsequent donation behavior and potential sex, race, and ethnic group differences

Christopher R. France, Janis L. France, Dominic W. Ysidron, Caroline D. Martin, Louisa Duffy, Debra A. Kessler, Mark Rebosa, Shiraz Rehmani, Victoria Frye, Beth H. Shaz

Summary: This study investigated the motivators and barriers of young, first-time blood donors and found that prosocial motivation was the most commonly reported motivator, while fear was the most commonly reported barrier. The reported motivators and barriers were not significantly related to donation behavior, but certain barriers such as fear of fainting/dizziness, fear of needles/pain, personal commitments conflicting with donating, and perceiving oneself as unsuited to donate for health reasons were significantly associated with donation behavior. Differences in motivators and barriers were also observed among different sexes, races, and ethnicities.

TRANSFUSION (2022)

Meeting Abstract Cell & Tissue Engineering

Abstract 12 Phase I Study of Cord Tissue Derived Mesenchymal Stromal Cells in COVID-19-Related Acute Respiratory Distress Syndrome

Bryan Kraft, Linda Brown, Margaret Scott, Frank Vrionis, Ralph Palumbo, Jesse Troy, Emily Poehlein, Lynn Cheatham, Lingye Chen, Joanne Kurtzberg, Raha Manyara, Khalid Hanafy, Beth Shaz

STEM CELLS TRANSLATIONAL MEDICINE (2022)

Meeting Abstract Cell & Tissue Engineering

Improving Cord Blood Unit Selection and Optimizing Manufacturing of a Unique Cord Blood-Derived Product (DUOC-01)

April Ozamiz, Kevin Shoulars, Pamela Noldner, Beth Shaz, Joanne Kurtzberg

STEM CELLS TRANSLATIONAL MEDICINE (2022)

Meeting Abstract Cell & Tissue Engineering

Limitations of Current Human Cell, Tissue, and Cellular-based Product Donor Eligibility Guidance: Analyzing the Impact on a Large Public Cord Blood Bank

Dana S. Guggenheim, Joanne Kurtzberg, Beth Shaz

STEM CELLS TRANSLATIONAL MEDICINE (2022)

Meeting Abstract Cell & Tissue Engineering

Abstract 18 Developing a Potency Assay for Cord Tissue MSCs

Roberta Parrott, Pamela Noldner, Li Xu, Anthony Filiano, Beth Shaz, Joanne Kurtzberg

STEM CELLS TRANSLATIONAL MEDICINE (2022)

Article Education, Scientific Disciplines

Expanding the platelet inventory to mitigate the impact of severe short ages

James R. Stubbs, Beth H. Shaz, Ralph R. Vassallo, John D. Roback

Summary: This passage mainly discusses the platelet collection system based on volunteer nonremunerated donors and apheresis platelet collections, which usually provides therapeutic support for hundreds of thousands of patients annually. However, during the coronavirus disease 2019 pandemic, especially during the Omicron wave, the system experienced significant failures and severe shortages. Four initiatives are proposed to reinforce the existing platelet pipeline and buffer the platelet supply against future unexpected disruptions.

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2022)

Article Multidisciplinary Sciences

The potential cost-effectiveness of novel cord blood therapies in children with autism spectrum disorder

Ethan D. Borre, Evan Myers, Marianne Hamilton Lopez, Joanne Kurtzberg, Beth Shaz, Jesse Troy, Gillian D. Sanders Schmidler

Summary: This study used a Markov microsimulation to model the long-term clinical and economic outcomes of potential cord blood therapy in autism spectrum disorder (ASD). The results showed that cord blood therapy can be a cost-effective intervention under certain circumstances.

PLOS ONE (2023)

Article Cell & Tissue Engineering

Feasibility Study of Cord Tissue Derived Mesenchymal Stromal Cells in COVID-19-Related Acute Respiratory Distress Syndrome

Beth H. Shaz, Bryan D. Kraft, Jesse D. Troy, Emily Poehlein, Lingye Chen, Lynn Cheatham, Raha Manyara, Khalid Hanafy, Linda Brown, Margaret Scott, Ralph Palumbo, Frank Vrionis, Joanne Kurtzberg

Summary: This study explores the feasibility and safety of using allogeneic human umbilical cord derived mesenchymal stromal cells (hCT-MSCs) for treating COVID-19-related acute respiratory distress syndrome (ARDS). The results show that this treatment method is feasible and safe in clinical practice, without any related adverse reactions. However, further research is needed to explore its safety and efficacy.

STEM CELLS TRANSLATIONAL MEDICINE (2023)

Editorial Material Cell & Tissue Engineering

Cord Blood Connect 2023 Abstracts

Beth H. Shaz

STEM CELLS TRANSLATIONAL MEDICINE (2023)

Meeting Abstract Cell & Tissue Engineering

LOCAL MANUFACTURING PROCESSES CONTRIBUTE TO VARIABILITY IN HUMAN MESENCHYMAL STROMAL CELL (MSC) EXPANSION WHILE GROWTH MEDIA SUPPLEMENTS CONTRIBUTE TO VARIABILITY IN GENE EXPRESSION AND CELL FUNCTION. THE BEST COLLABORATIVE STUDY

B. Shaz, R. Schaefer, M. Fontaine, P. Norris, D. McKenna, B. Miyazawa, P. Jin, J. Reems, D. Stroncek, M. Takanashi, D. C. Marks, H. Geng, S. Pati

CYTOTHERAPY (2023)

Meeting Abstract Hematology

Effects of Blood Donor Iron Deficiency on Red Cell Quality for Transfusion and on Donor Quality of Life and Cognition: The DIDS Randomized Clinical Trial

Eldad A. Hod, Gary M. Brittenham, Zachary Bitan, Yona Feit, Jordan Gaelen, Francesca La Carpia, Luke Sandoval, Alice Zhou, Joseph Schwartz, Donald McMahon, Debra A. Kessler, Beth H. Shaz, Richard O. Francis, Steven L. Spitalnik

TRANSFUSION (2022)

Meeting Abstract Cell & Tissue Engineering

SAFETY OF CORD TISSUE DERIVED MESENCHYMAL STROMAL CELLS IN COVID-19 RELATED ACUTE RESPIRATORY DISTRESS SYNDROME

B. Shaz, B. Kraft, J. Troy, E. Poehlein, L. Chen, L. Cheatham, R. Manyara, K. Hanafy, L. Brown, M. Scott, R. Palumbo, F. Vrionis, J. Kurtzberg

CYTOTHERAPY (2022)

暂无数据